Dr. Mark Filiaggi, Department of Applied Oral Sciences, along with co-investigators Dr. Bob Abraham and PhD student Arash Momeni, has been awarded $49,500 of Early Stage Commercialization Funding from Innovacorp for "Commercialization of CaP Liquid Embolic System."
This funding will help develop and commercialize a liquid embolic material. This new material is designed to be injected into blood vessels where it will form a solid or gel-like embolus (blockage).
Embolization is commonly used to stop uncontrolled bleeding or to block blood flow to a target tissue, such as a tumour. The researchers believe this new material will have several advantages over existing liquid embolics and intend to initially focus its use on the treatment of tumours.
Recent News
- How I spent my summer: Seeing the light in the lab
- Why attend a reunion
- DentDays 2024 ‑ A message from the dean
- Our 2024 OAA recipients
- Grad profile: Haider Hussain
- Grad profile: Mariam El‑Aghil
- Grad profile: Annie Jacob
- Jillian Bishop receives the 2024 Dr. D. S. Precious Gold Medal in Dentistry